Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News cbdMD Inc YCBD

Healthcare Biotechnology
cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including... see more

Recent & Breaking News (NYSEAM:YCBD)

Herbal Oasis Expands Footprint with New Distribution Agreement in Georgia

Newsfile May 21, 2025

cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

Newsfile May 15, 2025

cbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year 2025 Results

Newsfile May 9, 2025

Herbal Oasis Expands Southeast Presence with New Distribution Agreement in North Carolina

Newsfile May 7, 2025

Herbal Oasis Wins National Recognition at the 2025 High Spirits Awards

Newsfile April 24, 2025

cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion

Newsfile April 21, 2025

cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

Newsfile April 10, 2025

Herbal Oasis Announces Distribution Agreement to Launch Statewide in Alabama and Select Florida Panhandle Markets

Newsfile April 8, 2025

cbdMD Achieves Key Milestone in UK Novel Food Regulatory Approval

Newsfile April 7, 2025

cbdMD Generates $5.1 Million in Revenue, Positive Earnings

Newsfile February 13, 2025

cbdMD, Inc. to Host Conference Call to Discuss December 31, 2024 First Quarter of Fiscal Year 2025 Results

Newsfile February 7, 2025

cbdMD Announces It Has Fully Satisfied Its Notes

Newsfile January 15, 2025

cbdMD Announces Additional Conversions of Its Convertible Notes

Newsfile January 8, 2025

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standard

Newsfile January 3, 2025

cbdMD Announces Company's CEO Joins the Board of Directors

Newsfile December 23, 2024

cbdMD Generates $19.1 Million in Year Over Year Reduction in Net Loss Improvement

Newsfile December 18, 2024

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

Newsfile December 18, 2024

cbdMD, Inc. Reschedules Earnings Release and Conference Call

Newsfile December 17, 2024

cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results

Newsfile December 12, 2024

cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers

Newsfile November 14, 2024